by European Public Health Alliance | May 24, 2016 | News Release, Statements
EPHA calls on the Commission to present evidence that TTIP will actually lead to lower prices for medicines in Europe, rather than a convergence with the even higher prices that are today’s reality in the USA. Affordability of medicines should be included as a key...
by European Public Health Alliance | May 24, 2016 | News Release, Statements
Affordability of medicines The European Commission maintains that closer cooperation on trade in medicines in TTIP will lead to cost savings for pharmaceutical companies. However, it is not clear that any cost savings will translate to lower prices of medicines for...
by European Public Health Alliance | May 3, 2016 | Opinion
EPHA believes that greater transparency is vital to ensure proper democratic and public debate about the impact of trade policy on population health, following Greenpeace Netherlands’ release of classified TTIP negotiating documents By Zoltán Massay-Kosubek, Policy...
by European Public Health Alliance | May 2, 2016 | News Release, Statements
EPHA believes that greater transparency is vital to ensure proper democratic and public debate about the impact of trade policy on population health, following Greenpeace Netherlands’ release of classified TTIP negotiating documents. Brussels, 2nd May 2016. EPHA...
by European Public Health Alliance | Apr 6, 2016 | Opinion
Could the Commission’s ambition to make the TTIP trade deal between the EU and USA a ‘living agreement’ come with harmful side effects? An analysis of the European Commission’s revised proposals for Regulatory Cooperation and Good Regulatory Practices suggests...